DoW Orthopaedic, Applied Research Award | HT942526ORPARA

DoW Orthopaedic, Applied Research Award (ARA) - FAQs

What is the DoW Orthopaedic, Applied Research Award (ARA)?

The DoW Orthopaedic, Applied Research Award (ARA) is a discretionary grant opportunity under the Department of Defense Orthopaedic Research Program (ORP). It is administered through the Defense Health Agency Contracting Activity (DHACA) and supports science and technology research and development projects aimed at improving treatment and restoring function for people with orthopaedic injuries linked to combat or other service-related activities.

What is the main goal of this award?

The central goal is to move beyond basic discovery and push promising ideas closer to practical, usable solutions that can make a real difference in military and Veteran health settings. The program is positioned for teams that are ready to advance an approach toward implementation or later-stage testing, rather than starting from scratch.

What does "applied research" mean for this opportunity?

Applied research under this award means taking existing concepts and refining them into potential solutions while actively assessing technical feasibility. The expectation is that the work will be grounded in prior progress and focused on whether an approach can realistically work and be advanced.

What kinds of projects or products can be supported?

Examples of supported applied research outputs include development and early evaluation of new knowledge products, pharmacologic agents, behavioral or rehabilitation interventions, diagnostic or therapeutic techniques, clinical guidance, and other emerging approaches or technologies that are relevant to orthopaedic injury care and recovery.

Are purely exploratory or basic discovery projects appropriate?

No. Proposals are expected to go beyond purely exploratory work. The program description emphasizes advancing promising ideas toward feasible solutions, not conducting early-stage basic discovery without a pathway toward practical application.

Is preliminary data required?

Yes. Preliminary data is required, meaning applicants need to provide credible evidence that the approach is workable and justified. This can include prior results, pilot findings, proof-of-concept demonstrations, or other supporting data that reduces technical risk and shows readiness for applied advancement.

Why is preliminary data emphasized so strongly?

The award is designed for applied advancement, so reviewers are likely to look for evidence that the proposed work is built on a foundation of prior progress. This requirement helps demonstrate that the project is not beginning from a blank slate and is positioned to test feasibility and move toward real-world usability.

What is meant by "military relevance" for this award?

Military relevance is a core requirement. Proposals should clearly connect the research problem and anticipated outcomes to needs arising from military service-related orthopaedic injuries. The ORP expects results will benefit Service Members, their families, and Veterans, with possible additional benefits to the general public.

Who is expected to benefit from the research results?

The primary expected beneficiaries are Service Members, their families, and Veterans. The program also notes that there may be spillover benefits to the general public, but the proposal should clearly address military service-related needs.

Is clinical research allowed under this award?

No. Clinical research is not allowed under this mechanism. Applicants should plan non-clinical applied research activities that still advance feasible solutions while avoiding study elements that would be considered clinical research by the sponsor.

What types of non-clinical activities might fit within the scope?

The opportunity description gives examples such as technology development, preclinical testing, benchtop validation, algorithm development and validation using appropriate non-clinical datasets, and development of clinical guidance approaches that do not involve conducting clinical research as defined by the sponsor.

How should applicants handle the restriction on clinical research?

Applicants should design projects carefully to remain on the non-clinical side of applied research. The description notes that the restriction can be interpreted strictly depending on program definitions, so proposals should avoid human-subject clinical research elements that could make the project nonresponsive or out of scope.

What is the funding opportunity number for this award?

The funding opportunity number (FON) is HT942526ORPARA.

What CFDA number is associated with this opportunity?

The listing includes CFDA number 12.420.

Who is eligible to apply?

Eligibility is listed as unrestricted in the provided summary, meaning no applicant-type limitations are stated there (for example, it is not listed as limited only to universities or nonprofits).

What is the application deadline?

The posted original closing date is 2026-11-18.

How many awards are expected to be made?

The opportunity anticipates making about 4 awards.

Is there an award ceiling or maximum budget listed?

No award ceiling is specified in the provided listing. Applicants may need to consult the full funding announcement for budget limits, the period of performance, cost constraints, and any program-specific caps.

What kinds of teams are best suited for this award?

This award is best suited for teams that already have supporting preliminary results and are ready to translate orthopaedic injury-related innovations into practical, technically feasible solutions. Projects should be oriented toward real-world military and Veteran health impact while remaining clearly non-clinical.

What is the overall program focus within orthopaedics?

The focus is on improving treatment and restoring function for individuals with orthopaedic injuries connected to combat or other service-related activities, with an emphasis on solutions that could matter in military and Veteran health settings.